Having previously identified a C-terminally truncated form of MRE11 (TR-MRE11) in the bladder cancer cell line RT112, and in T24 bladder cancer cells following HDAC inhibition by panobinostat treatment13, we extended our cell line panel to include seven other bladder cancer cell lines (Fig. 1A). The gene discussed is MRE11; the disease is urinary bladder cancer.